Premedication in dogs: dexmedetomidine vs acepromazine (each with buprenorphine) — POSSIBLE (the treatment made no difference)

In dogs, does dexmedetomidine vs acepromazine premedication give better sedation with fewer cardiovascular derangements before anaesthesia?

Shelf #317 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE (the treatment made no difference): On sedation, dexmedetomidine did not beat acepromazine in either randomised blinded trial. Bell 2011 randomised 60 healthy dogs (ASA grades I/II) to buprenorphine with acepromazine or with dexmedetomidine at two doses: there were no significant differences in sedation or quality of induction between groups. Hunt 2013 (Grint a co-author), a prospective randomized blinded clinical study of buprenorphine with dexmedetomidine or acepromazine before elective surgery, likewise found no differences in sedation in dogs. On cardiovascular effects, dexmedetomidine did not produce fewer derangements — it produced a different pattern: after premedication in Bell 2011, heart rate was significantly lower and arterial blood pressures higher in both dexmedetomidine groups than in the acepromazine group. Where dexmedetomidine did differ was induction-agent sparing: in Hunt 2013 propofol doses were lower in dexmedetomidine dogs (1.5 ± 0.8 mg kg-1) than acepromazine dogs (3.3 ± 1.1 mg kg-1) (p < 0.001), and in Bell 2011 the higher-dose dexmedetomidine group's propofol target was significantly lower than the acepromazine group's (1.5 vs 2.5 μg mL-1, medians). So the answer to the shelf question as asked is no on both halves: no better sedation, and a bradycardia-and-higher-pressure pattern rather than fewer cardiovascular changes. Drafted Nov 10, 2026 (VetMed build, topic #317); all figures from abstracts fetched and verified at drafting.

Bell 2011: no difference in sedation or induction quality between dexmedetomidine and acepromazine premedication in 60 dogs (the treatment made no difference) — heart rate lower and blood pressure higher on dexmedetomidine

Prospective, randomised, blinded clinical study (record's own design wording)

Who: Dogs: 60 healthy dogs (ASA grades I/II), mean body mass 28.0 ± 9.1 kg and mean age 3.4 ± 2.3 years, in a clinical premedication study — breed is not stated in the record. Dogs were allocated randomly to intramuscular buprenorphine 15 μg kg-1 combined with acepromazine 30 μg kg-1 (group 1), dexmedetomidine 62.5 μg m-2 (group 2), or dexmedetomidine 125 μg m-2 (group 3), with propofol target-controlled infusion induction after 30 minutes.

Result: There were no significant differences in sedation or quality of induction between groups. After premedication, heart rate was significantly lower and arterial blood pressures higher in groups 2 and 3 than in group 1, with no significant difference between groups 2 and 3. Propofol targets required for endotracheal intubation were significantly lower in group 3 (1.5 (1.0–2.5) μg mL-1, median (IQR)) than in group 1 (2.5 (2.0–3.0) μg mL-1); group 2 (2.0 (1.5–2.5) μg mL-1) did not differ significantly from the other groups. Age was significantly lower in group 1 than group 2. The authors conclude that, with buprenorphine at these doses, dexmedetomidine had no advantages in terms of sedation and induction quality over acepromazine.

Watch out: Both drugs were given with buprenorphine, so this is a comparison of combinations, not of dexmedetomidine and acepromazine alone. Sedation was scored on a 4-point scale, a coarse instrument that could miss small differences. The significant age imbalance (group 1 younger than group 2) is reported in the record.

Bell AM, Auckburally A, Pawson P, Scott EM, Flaherty D. Two doses of dexmedetomidine in combination with buprenorphine for premedication in dogs; a comparison with acepromazine and buprenorphine. Vet Anaesth Analg. 2011;38(1):15-23. PMID: 21214706. Registry ID: none in the record. MeSH: Acepromazine/administration & dosage,pharmacology · Analgesics, Opioid/administration & dosage,therapeutic use · Animals · Buprenorphine/administration & dosage,pharmacology · Dexmedetomidine/administration & dosage,pharmacology · Dogs · Dopamine Antagonists/administration & dosage,therapeutic use · Dose-Response Relationship, Drug · Drug Therapy, Combination · Female · Hypnotics and Sedatives/administration & dosage,therapeutic use · Male · Preanesthetic Medication/veterinary

Hunt 2013: no difference in sedation in dogs between buprenorphine + dexmedetomidine and buprenorphine + acepromazine (the treatment made no difference) — propofol induction dose lower on dexmedetomidine

Prospective, randomized, blinded clinical study (record's own design wording)

Who: Dogs: 40 dogs (the study also enrolled 48 cats, not carded here) undergoing elective surgery, premedicated intramuscularly with buprenorphine 20 μg kg-1 with either dexmedetomidine 250 μg m-2 or acepromazine 0.03 mg kg-1, followed by alfaxalone or propofol induction and isoflurane maintenance, with meloxicam given preoperatively to all animals. Breed is not stated in the record.

Result: There were no differences in sedation in dogs between the dexmedetomidine and acepromazine groups. Propofol doses were lower in dexmedetomidine dogs (1.5 ± 0.8 mg kg-1) compared to acepromazine dogs (3.3 ± 1.1 mg kg-1) (p < 0.001). There were no differences between groups with respect to pain scores or mechanical nociceptive threshold for cats or dogs. The authors conclude that choice of dexmedetomidine or acepromazine with buprenorphine caused minor, clinically detectable differences in various characteristics of anaesthesia, but not in the level of analgesia.

Watch out: The dog sedation result comes from a mixed cat-and-dog study in which the headline sedation difference (dexmedetomidine more sedated) was in cats, not dogs — the dog-specific result is the null one carded here. Two induction agents (alfaxalone or propofol) were used within the same study. This is the record behind the draft 'Grint et al.' anchor: Grint NJ is second author, with Hunt JR as first author (2013, not 2009–2010).

Hunt JR, Grint NJ, Taylor PM, Murrell JC. Sedative and analgesic effects of buprenorphine, combined with either acepromazine or dexmedetomidine, for premedication prior to elective surgery in cats and dogs. Vet Anaesth Analg. 2013;40(3):297-307. PMID: 23279623. Registry ID: none in the record. MeSH: Acepromazine/administration & dosage,pharmacology · Analgesics, Opioid/administration & dosage,pharmacology · Animals · Buprenorphine/administration & dosage,pharmacology · Cats/physiology · Dexmedetomidine/administration & dosage,pharmacology · Dogs/physiology · Dopamine Antagonists/administration & dosage,pharmacology · Drug Therapy, Combination · Female · Hypnotics and Sedatives/administration & dosage,pharmacology · Male · Premedication

Synthesis: dexmedetomidine does not sedate dogs better than acepromazine when both are paired with buprenorphine, and its cardiovascular pattern is different, not smaller

Synthesis

Who: Synthesis of the cards above: healthy and elective-surgery dogs in two randomised blinded clinical premedication studies (Bell 2011, 60 dogs; Hunt 2013, 40 dogs), all receiving buprenorphine with either dexmedetomidine or acepromazine.

Result: Two independent randomised blinded trials agree on no sedation advantage for dexmedetomidine in dogs (the treatment made no difference). The reproducible dexmedetomidine advantages are induction-agent sparing (lower propofol dose/target in both trials) and its reproducible cardiovascular costs are lower heart rate and higher arterial pressure after premedication. Choosing between them is therefore a choice about induction dose and cardiovascular pattern, not about depth of sedation.

Watch out: All carded evidence pairs both sedatives with buprenorphine and studies mainly healthy ASA I/II or elective-surgery dogs; the balance does not extend to sick dogs, to either drug used alone, or to medetomidine. Grint 2009 (dexmedetomidine with or without pethidine, PMID: 19037885) was checked and not carded: it has no acepromazine arm, so it cannot answer this shelf's question.

Synthesis of Bell AM et al. PMID: 21214706; Hunt JR et al. PMID: 23279623. Registry ID as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.